Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorCivaTech Oncology

About this trial

Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor removal.

Eligibility criteria

Qualifiers

• Subject signed inform consent

Age > 18 years

Not pregnant or breast feeding

Patient capable of undergoing anesthesia

Disqualifiers

Not surgical candidate

Any other invasive cancer in the past 5 years, except basal cell or squamous cell skin cancer

An IRE candidate (IRE is Percutaneous irreversible electroporation)

Recurrent or previously resected tumors

Trial design

Treatments tested in this trial

  • Directional Brachytherapy Source Implant

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators